Treatment type: Immunotherapies
-
‘Missing link’ explains how viruses trigger immunity
A discovery by Melbourne researchers has solved a longstanding mystery of how viruses trigger protective immunity within our body. The research team demonstrated a protein called SIDT2 was crucial for cells to detect viral components in their environment, and initiate an immune response to reduce the virus’ spread. As well as being an important part… Read more
-
Promising new treatment for incurable premature lung disease
Hudson Institute researchers have discovered a potential safe and effective treatment for bronchopulmonary dysplasia (BPD), which could save preterm babies from the severe lifelong effects of this incurable premature lung disease.… Read more
-
Protein found in female reproductive tract could halt HIV spread
Scientists from Hudson Institute of Medical Research and Deakin University have shown that a naturally occurring signalling protein found in the female reproductive tract, interferon epsilon, can block the replication of human immunodeficiency virus (HIV) in human cells, and could form a first-line response to the virus.… Read more
-
WWI antiseptic could fight 21st century viral infections
Melbourne researchers have shown that a century-old topical antiseptic used to treat wounds and ‘sleeping sickness’ in Australian soldiers in World War One could activate the immune system to protect against viral infection, and may prove key in the fight against antibiotic resistance.… Read more
-
Researchers identify key driver of devastating muscle wasting disease affecting cancer patients
Lung cancer is the leading cause of cancer death worldwide, and is frequently associated with cachexia. Cachexia is a devastating syndrome of weight and muscle wasting, affecting as many as 80 per cent of advanced cancer patients.… Read more
-
Breakthrough heralds hope for advanced bladder cancer patients
Researchers at Hudson Institute of Medical Research have discovered a crucial genetic marker that heralds better treatment and outcomes for patients with advanced bladder cancer.… Read more
-
Researchers identify protein to prevent damage to donated vital organs
Melbourne researchers have identified a protein (follistatin) that could prevent damage to donated organs before and after transplantation, and potentially stop the body rejecting the… Read more
-
Delegates to tour MHTP during International Congress of Immunology 2016
International delegates will visit Hudson Institute of Medical Research during the 16th International Congress of Immunology 2016 in Melbourne on Tuesday, August 23. Around 3000 immunology researchers and experts will converge on Melbourne for ICI, one of the largest meetings of its kind. The main theme for ICI 2016 is “Immunotherapy: Harnessing the Power of the… Read more
-
Hudson Institute discovery could help ‘buy time’ during global avian influenza pandemic
A team of researchers at Hudson Institute of Medical Research have found that timely blocking of the body’s own immune response to infection from a severe or pathogenic strain of influenza could be vital in treating patients infected during a global pandemic.… Read more
-
Grants and fellowships enable and extend life-saving research at the Hudson
Six Hudson Institute researchers working in the areas of fetal and neonatal health, cancer and reproductive health have received grants and fellowships to build on and enhance their life-saving research.… Read more